Free Trial

Growth Stocks To Consider - May 12th

Novo Nordisk A/S logo with Medical background

Novo Nordisk A/S, Prologis, Blackstone, Apollo Global Management, and BlackRock are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow revenues and earnings at a significantly faster pace than the overall market, often because they reinvest profits into research, development, and expansion rather than paying out dividends. Investors buy growth stocks for capital appreciation, accepting higher valuations and potentially greater price volatility in exchange for the prospect of above-average long-term returns. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Shares of NYSE NVO traded up $1.82 during mid-day trading on Monday, hitting $67.59. The stock had a trading volume of 14,321,345 shares, compared to its average volume of 9,304,139. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.55 and a current ratio of 0.74. Novo Nordisk A/S has a twelve month low of $57.00 and a twelve month high of $148.15. The firm has a market cap of $303.33 billion, a PE ratio of 20.53, a PEG ratio of 0.90 and a beta of 0.65. The company has a 50 day moving average of $69.21 and a two-hundred day moving average of $85.83.

Read Our Latest Research Report on NVO

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

NYSE:PLD traded up $4.48 during trading hours on Monday, reaching $111.39. 4,669,413 shares of the company were exchanged, compared to its average volume of 4,164,757. The firm has a market cap of $103.37 billion, a PE ratio of 27.85, a price-to-earnings-growth ratio of 2.70 and a beta of 1.25. Prologis has a twelve month low of $85.35 and a twelve month high of $132.57. The stock's 50-day moving average is $105.95 and its 200-day moving average is $111.30. The company has a current ratio of 0.75, a quick ratio of 0.43 and a debt-to-equity ratio of 0.53.

Read Our Latest Research Report on PLD

Blackstone (BX)

Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.

Blackstone stock traded up $9.24 during mid-day trading on Monday, reaching $148.63. 3,293,213 shares of the company's stock were exchanged, compared to its average volume of 4,645,697. The company has a quick ratio of 0.71, a current ratio of 0.67 and a debt-to-equity ratio of 0.61. The company has a fifty day moving average of $136.87 and a 200-day moving average of $162.18. The company has a market cap of $108.45 billion, a P/E ratio of 40.95, a P/E/G ratio of 1.07 and a beta of 1.67. Blackstone has a twelve month low of $115.66 and a twelve month high of $200.96.

Read Our Latest Research Report on BX

Apollo Global Management (APO)

Apollo Global Management, Inc. is a private equity firm specializing in investments in credit, private equity, infrastructure, secondaries and real estate markets. The firm prefers to invest in private and public markets. The firm's private equity investments include traditional buyouts, recapitalization, distressed buyouts and debt investments in real estate, corporate partner buyouts, distressed asset, corporate carve-outs, middle market, growth, venture capital, turnaround, bridge, corporate restructuring, special situation, acquisition, and industry consolidation transactions.

NYSE APO traded up $10.31 during trading on Monday, reaching $142.77. The company's stock had a trading volume of 2,932,626 shares, compared to its average volume of 3,877,729. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.44 and a current ratio of 1.44. The firm has a market cap of $81.45 billion, a price-to-earnings ratio of 19.52, a P/E/G ratio of 1.17 and a beta of 1.67. Apollo Global Management has a twelve month low of $95.11 and a twelve month high of $189.49. The business's fifty day moving average price is $131.82 and its 200-day moving average price is $152.59.

Read Our Latest Research Report on APO

BlackRock (BLK)

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

BLK stock traded up $35.34 during trading on Monday, hitting $958.78. The stock had a trading volume of 364,394 shares, compared to its average volume of 684,930. The stock has a market cap of $148.85 billion, a price-to-earnings ratio of 22.83, a price-to-earnings-growth ratio of 1.90 and a beta of 1.41. The company has a debt-to-equity ratio of 0.45, a quick ratio of 5.23 and a current ratio of 5.23. The company's 50 day moving average price is $913.01 and its two-hundred day moving average price is $978.40. BlackRock has a 1-year low of $752.30 and a 1-year high of $1,084.22.

Read Our Latest Research Report on BLK

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Novo Nordisk A/S Right Now?

Before you consider Novo Nordisk A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.

While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines